The Antibody Lab reports positive evaluation of Horizon 2020 project

The Antibody Lab with its Horizon 2020 project proposal on clinical validation of its proprietary marker NT-proCNP for pregnancy complications was successful in a highly competitive evaluation process. The proposal has been recommended for funding by other sources due to budget constraints of the EC.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)